Richard Chin
Chief Executive Officer, Oncotelic Therapeutics, Inc.
Companies
- Cytek Biosciences, Inc.Board member Jun 20, 2025 to now1
- Kindred Biosciences, Inc.Board member Dec 11, 2013 to Aug 30, 20212
- Kindred Biosciences, Inc.Chief executive officer Dec 11, 2013 to Aug 30, 20212
- Kindred Biosciences, Inc.President Dec 11, 2013 to Oct 3, 20182
- Galena BiopharmaBoard member Apr 27, 2009 to Oct 10, 20173
- Oncotelic Therapeutics, Inc.Board member Jul 7, 2006 to Jan 15, 20084
- Oncotelic Therapeutics, Inc.Chief executive officer Jul 7, 2006 to Jan 15, 20084
- Oncotelic Therapeutics, Inc.President Jul 7, 2006 to Jan 15, 20084
Holdings
Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.
Shares held
- Cytek Biosciences, Inc. CTKB28,499 shares5$149.2K at $5.24Aug 18, 2026
As of each latest filing. The line shows shares held over time.
Recent filings
- Aug 18, 2026Exercised options 6,107 shares of Cytek Biosciences, Inc.5
- May 18, 2026Exercised options 6,107 shares of Cytek Biosciences, Inc.6
- Mar 10, 2026Exercised options 6,107 shares of Cytek Biosciences, Inc.7
- Nov 18, 2025Exercised options 6,107 shares of Cytek Biosciences, Inc.8
- Aug 18, 2025Exercised options 4,071 shares of Cytek Biosciences, Inc.9
Sources
The numbers on this page point here. Each one links to the record it came from.
- 1
- 2
- 3SEC EDGARGalena Biopharma, Board member
- 4
- 5
- 6SEC EDGARForm 4 filed May 20, 2026
- 7SEC EDGARForm 4 filed Mar 12, 2026
- 8SEC EDGARForm 4 filed Nov 20, 2025
- 9SEC EDGARForm 4 filed Aug 20, 2025